Panacea Biotec Limited announced a leadership change at the board level, revealing that Mukul Gupta has completed his second and final five-year term as an Independent Director on March 31, 2026. With the term concluded, Gupta ceased to be an Independent Director and also stepped away from chairing or serving on the company’s board committees.
The board and management expressed deep appreciation for Gupta’s extensive contribution and guidance, noting his role in steering Panacea Biotec’s trajectory during a period of growth and transformation. His tenure reflects a sustained emphasis on governance and independent oversight as the company advances its strategic priorities.
Panacea Biotec continues to navigate its path forward with a commitment to strong governance practices and robust board composition that supports its long-term objectives. The company did not indicate any immediate replacements, but the leadership team and board will align on next steps to maintain continuity and oversight for the organization.’